Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
doi:10.1001/jamapsychiatry.2024.4789
Members access regularly updated protocol recommendations based on the most recent clinical data, community experience, and expert analysis
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
They can also be used as a monotherapy or in combination with other drugs
PMID 12864730
Since GLP-1 medications significantly reduce appetite, Gendreau says every bit of food you put in your mouth has to meaningfully count
